Skip to NavigationSkip to content

News

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster drug discovery...
Check out this week's top 10 most popular stories on Pharmafile.com!
It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices of more than 20 of its products, many...
Senator Bernie Sanders has called on President Donald Trump to support new legislation aimed at cutting prices on prescription drugs.
A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into chronic conditions -...
UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two sites in the US state of Colorado...
Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects against all...
It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS use for the...
The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in October alone, it has emerged.
Commonly used anti-cholesterol drugs, blood pressure drugs and medicines used for diabetes may improve the mental health of those with severe...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches